Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01818 |
| Species: | Homo sapiens |
| Position : | chr11:69419632-69420080 |
| Year: | 2022 |
| Title: | The renal lineage factor PAX8 controls oncogenic signalling in kidney cancer. |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | renal cell carcinoma |
| PMID: | 35676472 |
| MONDO: | MONDO:0005086 |
| Tissue: | kidney |
| Tissue Ontology ID: | UBERON:0002113 |
| Cell Source: | 786-M1A |
| CVCL ID: | CVCL_VR30 |
| Cell Type: | malignant cell |
| Cell Ontology ID: | CL:0001064 |
| Experiment Type: | Enhancer activity assay; TF binding assay; Functional perturbation assay; Disease-variant functional analysis |
| High Throughput Method: | Pooled in vivo CRISPRi screen; ATAC-seq; ChIP-seq |
| Low Throughput Method: | CRISPRi; RT-qPCR; ChIP-qPCR |
| Target gene : | MYEOV |
| TF name : | EPAS1 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| EPAS1 | HIF-2-alpha transcription factor network | pid | 34 |
| EPAS1 | Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | reactome | 18 |
| EPAS1 | PTK6 Expression | reactome | 5 |
| EPAS1 | Regulation of gene expression by Hypoxia-inducible Factor | reactome | 10 |
| EPAS1 | Transcriptional regulation of pluripotent stem cells | reactome | 28 |
| EPAS1 | Pathways in cancer | kegg | 321 |
| EPAS1 | Renal cell carcinoma | kegg | 65 |